4-Bromobenzyl bromide structure
|
Common Name | 4-Bromobenzyl bromide | ||
|---|---|---|---|---|
| CAS Number | 3433-80-5 | Molecular Weight | 249.930 | |
| Density | 1.9±0.1 g/cm3 | Boiling Point | 253.0±15.0 °C at 760 mmHg | |
| Molecular Formula | C7H6Br2 | Melting Point | 29-32 °C(lit.) | |
| MSDS | USA | Flash Point | 118.0±19.6 °C | |
| Symbol |
GHS05 |
Signal Word | Danger | |
| Name | 1-bromo-2-(bromomethyl)benzene |
|---|---|
| Synonym | More Synonyms |
| Density | 1.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 253.0±15.0 °C at 760 mmHg |
| Melting Point | 29-32 °C(lit.) |
| Molecular Formula | C7H6Br2 |
| Molecular Weight | 249.930 |
| Flash Point | 118.0±19.6 °C |
| Exact Mass | 247.883606 |
| LogP | 3.69 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.606 |
| Storage condition | 0-6°C |
| Symbol |
GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | C:Corrosive |
| Risk Phrases | R23;R34;R37 |
| Safety Phrases | S26-S36/37/39-S45-S22 |
| RIDADR | UN 3261 8/PG 3 |
| WGK Germany | 3 |
| Packaging Group | III |
| Hazard Class | 8 |
| HS Code | 29036990 |
| Precursor 10 | |
|---|---|
| DownStream 10 | |
| HS Code | 2903999090 |
|---|---|
| Summary | 2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
|
Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.
J. Comb. Chem. 11(1) , 34-43, (2009) For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib... |
|
|
Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.
J. Comb. Chem. 11 , 14-33, (2009) Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa... |
|
|
Synthesis of quinazolines and tetrahydroquinazolines: copper-catalyzed tandem reactions of 2-bromobenzyl bromides with aldehydes and aqueous ammonia or amines.
Chem. Asian J. 9(3) , 739-43, (2014) An efficient synthesis of diversely substituted quinazolines and 1,2,3,4-tetrahydroquinazolines through copper-catalyzed tandem reactions of the readily available 2-bromobenzyl bromides, aldehydes, an... |
| p-Bromobenzyl-bromide |
| a,o-dibromotoluene |
| Benzene, 1-bromo-2-(bromomethyl)- |
| Benzene, 1-bromo-4- (bromomethyl)- |
| 1-Bromo-2-(bromomethyl)benzene |
| 4-Bromobenzyl bromide |
| |A,2-Dibromotoluene |
| ortho-2-bromo-benzyl bromide |
| α,p-Dibromotoluene |
| MFCD00000173 |
| Benzene, 1-bromo-4-(bromomethyl)- |
| EINECS 222-334-8 |
| 2-Bromobenzyl bromide |
| o-bromobenzyl bromide |
| α,2-Dibromotoluene |
| Toluene, p,α-dibromo- |
| 1-Bromo-4-(bromomethyl)benzene |
| ortho-bromo benzyl bromide |